Search - tctmd.com

Displaying 81 - 100 of 639

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

Presenter: Leonardo Sinnott Silva

October 29, 2024

Presentation TCT 2024

TCT 315: Acute and Long-Term Safety and Efficacy of IVUS-Guided Drug Coated Balloon Treatment for Carotid In-Stent Restenosis

Presenter: Piero Montorsi

October 29, 2024

Presentation TCT 2024

1. Clinical Challenges in Complex PCI and In-Stent Restenosis (ISR)

Presenter: Darshan Doshi

October 28, 2024

Presentation TCT 2024

TCT 488: Factors Associated With Chronic Stent Recoil and Its Impact on Revascularization: A Serial Optical Coherence Tomography Study

Presenter: Yoichiro SUGIZAKI

October 28, 2024

Presentation TCT 2024

TCT 491: AGENT Paclitaxel-Coated Balloon for the Treatment of In-Stent Restenosis in Small Vessel Coronary Lesions: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Suhail Dohad

October 28, 2024

Presentation TCT 2024

TCT 489: The Comparison of Tissue Characteristics of Restenosis After Coronary Interventions: Insights From a Histological Analysis After Directional Coronary Atherectomy

Presenter: Norihito Nakamura

October 28, 2024

Presentation TCT 2024

TCT 487: Preclinical Evaluation of a Novel Cryo-Balloon in the Porcine Coronary Model of In-Stent Restenosis

Presenter: Han Chen

October 28, 2024

Presentation TCT 2024

TCT 490: Intravascular Brachytherapy for Multilayer In-Stent Restenosis: 3-Year Clinical Outcomes

Presenter: Vishal Dhulipala

October 28, 2024

Presentation TCT 2024

TCT 492: One-Year Clinical Outcomes After PCI With AGENT Paclitaxel-Coated Balloon Among Underrepresented Racial and Ethnic Subgroups With In-Stent Restenosis: Analysis of the AGENT IDE Trial

Presenter: NULL

October 28, 2024

Presentation TCT 2024

TCT 1385: Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty to Treat Ostial Circumflex In-Stent Restenosis

Presenter: Fernando Cohen

October 27, 2024

News Conference News ESC 2024

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Todd Neale

September 09, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

Podcast TCTMD Talking Points

The AGENT IDE Trial

June 05, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

News Daily News

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

Todd Neale

May 03, 2024

News Industry News

Concept Medical Announces Enrollment of First Patient in “Magical-ISR” IDE Study in the US

April 19, 2024

Presentation Fellows 2024

Case and Technique Reviews: In-Stent Restenosis

Presenter: Jeffrey W. Moses

April 13, 2024

Presentation Fellows 2024

In-Stent Restenosis Treatment Identification and Treatment

Presenter: Evan Shlofmitz

April 11, 2024

Advertisement

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

TCT 315: Acute and Long-Term Safety and Efficacy of IVUS-Guided Drug Coated Balloon Treatment for Carotid In-Stent Restenosis

1. Clinical Challenges in Complex PCI and In-Stent Restenosis (ISR)

TCT 488: Factors Associated With Chronic Stent Recoil and Its Impact on Revascularization: A Serial Optical Coherence Tomography Study

TCT 491: AGENT Paclitaxel-Coated Balloon for the Treatment of In-Stent Restenosis in Small Vessel Coronary Lesions: A Subgroup Analysis of the AGENT IDE Randomized Trial

TCT 489: The Comparison of Tissue Characteristics of Restenosis After Coronary Interventions: Insights From a Histological Analysis After Directional Coronary Atherectomy

TCT 487: Preclinical Evaluation of a Novel Cryo-Balloon in the Porcine Coronary Model of In-Stent Restenosis

TCT 490: Intravascular Brachytherapy for Multilayer In-Stent Restenosis: 3-Year Clinical Outcomes

TCT 492: One-Year Clinical Outcomes After PCI With AGENT Paclitaxel-Coated Balloon Among Underrepresented Racial and Ethnic Subgroups With In-Stent Restenosis: Analysis of the AGENT IDE Trial

TCT 1385: Intravascular Ultrasound-Guided Drug-Coated Balloon Angioplasty to Treat Ostial Circumflex In-Stent Restenosis

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

TCTMD’s Top 10 Most Popular Stories for August 2024

DES Best for In-Stent Restenosis, but DCBs Also Viable

The AGENT IDE Trial

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

Concept Medical Announces Enrollment of First Patient in “Magical-ISR” IDE Study in the US

Case and Technique Reviews: In-Stent Restenosis

In-Stent Restenosis Treatment Identification and Treatment

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content